Modulation of Hexadecyl-LPA-Mediated Activation of Mast Cells and Microglia by a Chemical Probe for LPA5. (Q35904954)

11 August 2017

title

Modulation of Hexadecyl-LPA-Mediated Activation of Mast Cells and Microglia by a Chemical Probe for LPA5. (English)

1 reference

11 August 2017

0 references

0 references

Marc Nazare

9

0 references

author name string

Detlef H Kozian

1

1 reference

11 August 2017

Elisabeth von Haeften

2

1 reference

11 August 2017

Sabrina Joho

3

1 reference

11 August 2017

Werngard Czechtizky

4

1 reference

11 August 2017

Upendra R Anumala

5

1 reference

11 August 2017

Pascale Roux

6

1 reference

11 August 2017

Angela Dudda

7

1 reference

11 August 2017

Andreas Evers

8

1 reference

11 August 2017

language of work or name

1 reference

26 January 2016

1 reference

11 August 2017

1 reference

11 August 2017

volume

17

1 reference

11 August 2017

issue

9

1 reference

11 August 2017

page(s)

861-865

1 reference

High-throughput analysis of sphingosine 1-phosphate, sphinganine 1-phosphate, and lysophosphatidic acid in plasma samples by liquid chromatography-tandem mass spectrometry

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002/CBIC.201500559

LPA receptors: subtypes and biological actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CBIC.201500559

LPA5 Is Abundantly Expressed by Human Mast Cells and Important for Lysophosphatidic Acid Induced MIP-1β Release

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CBIC.201500559

Lysophosphatidic acid accelerates the development of human mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CBIC.201500559

Lysophosphatidic acid (LPA) induces plasma exudation and histamine release in mice via LPA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CBIC.201500559

The unexpected role of acid sphingomyelinase in cell death and the pathophysiology of common diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CBIC.201500559

Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CBIC.201500559

LPA is a chemorepellent for B16 melanoma cells: action through the cAMP-elevating LPA5 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CBIC.201500559

Molecular pharmacology of promiscuous seven transmembrane receptors sensing organic nutrients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CBIC.201500559

Lysophosphatidic acid inhibits CD8 T cell activation and control of tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CBIC.201500559

Targeted deletion of LPA5 identifies novel roles for lysophosphatidic acid signaling in development of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CBIC.201500559

Microglia and neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CBIC.201500559

Expression and function of lysophosphatidic acid receptors in cultured rodent microglial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CBIC.201500559

Lysophosphatidic acid-induced membrane ruffling and brain-derived neurotrophic factor gene expression are mediated by ATP release in primary microglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CBIC.201500559

Microglia and mast cells: two tracks on the road to neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CBIC.201500559

Selective non-lipid modulator of LPA5 activity in human platelets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CBIC.201500559

Lysophosphatidic acid receptor (LPAR) modulators: The current pharmacological toolbox

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CBIC.201500559

Establishment of an immature mast cell line from a patient with mast cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CBIC.201500559

Discovery of potent LPA2 (EDG4) antagonists as potential anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CBIC.201500559

MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CBIC.201500559

Lysophosphatidic acid triggers mast cell-driven atherosclerotic plaque destabilization by increasing vascular inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002/CBIC.201500559

21 January 2018

Identifiers

DOI

10.1002/CBIC.201500559

1 reference

11 August 2017

1 reference